ConductScience.org, home

Paper32085535

Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers.

Cojocaru FD and 9 others. Pharmaceutics, 2020. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers. Papers, record 32085535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32085535

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers.
PubMed
Journal
Pharmaceutics
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
7.52
iCite
Revised in PubMed
2020-09-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cojocaru FDFlorina-Danielahttps://orcid.org/0000-0002-8076-6414
2Botezat DDoru
3Gardikiotis IIoannis
4Uritu CMCristina-Marianahttps://orcid.org/0000-0002-7563-1267
5Dodi GGianinahttps://orcid.org/0000-0002-5551-6077
6Trandafir LLaura
7Rezus CCiprian
8Rezus EElena
9Tamba BIBogdan-Ionelhttps://orcid.org/0000-0001-9868-1999
10Mihai CTCosmin-Teodorhttps://orcid.org/0000-0002-0945-5437

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PN-III-P1-1.1-PD-2016-1642Ministry of Research and InnovationPubMed

Source PubMed

Download CSV of grants

References167

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130587980Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection.Int J Nanomedicine2018https://conductscience.org/library/papers/30587980PubMed
211779569Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes.Biochim Biophys Acta2002https://conductscience.org/library/papers/11779569PubMed
326315817Nano-enabled delivery of diverse payloads across complex biological barriers.J Control Release2015https://conductscience.org/library/papers/26315817PubMed
419014832Raltegravir: the first HIV integrase inhibitor.Clin Ther2008https://conductscience.org/library/papers/19014832PubMed
526612372Viral Skin Diseases.Prim Care2015https://conductscience.org/library/papers/26612372PubMed
626077630Adenoviral keratoconjunctivitis.Surv Ophthalmol2015https://conductscience.org/library/papers/26077630PubMed
724718923Neuraminidase inhibitors for preventing and treating influenza in adults and children.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24718923PubMed
829132524Hepatitis A and B Infections.Prim Care2017https://conductscience.org/library/papers/29132524PubMed
926489856PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread.Nanoscale Res Lett2015https://conductscience.org/library/papers/26489856PubMed
1027610014Hepatitis E: Discovery, global impact, control and cure.World J Gastroenterol2016https://conductscience.org/library/papers/27610014PubMed
1129642603Acyclovir-Loaded Chitosan Nanospheres from Nano-Emulsion Templating for the Topical Treatment of Herpesviruses Infections.Pharmaceutics2018https://conductscience.org/library/papers/29642603PubMed
1229894156Multivalent Flexible Nanogels Exhibit Broad-Spectrum Antiviral Activity by Blocking Virus Entry.ACS Nano2018https://conductscience.org/library/papers/29894156PubMed
1320466047Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat.Toxicol Lett2010https://conductscience.org/library/papers/20466047PubMed
1425402233Anti-HIV drug-combination nanoparticles enhance plasma drug exposure duration as well as triple-drug combination levels in cells within lymph nodes and blood in primates.AIDS Res Hum Retroviruses2015https://conductscience.org/library/papers/25402233PubMed
1527489270Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.J Virol2016https://conductscience.org/library/papers/27489270PubMed
1623963694A review of the toxicity of HIV medications.J Med Toxicol2014https://conductscience.org/library/papers/23963694PubMed
1724741339Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection.Clin Med Insights Womens Health2014https://conductscience.org/library/papers/24741339PubMed
1828748089The role of nanotechnology in the treatment of viral infections.Ther Adv Infect Dis2017https://conductscience.org/library/papers/28748089PubMed
1919073240Lecithin based nanoemulsions: A comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation.Int J Pharm2009https://conductscience.org/library/papers/19073240PubMed
2023089659Viral gastroenteritis in the adult population: the GI peril.Crit Care Nurs Clin North Am2012https://conductscience.org/library/papers/23089659PubMed

See all 167 referencesDownload CSV of references

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
42978664Nano-enabled approaches in virology: emerging strategies for rapid detection, antiviral therapy, and biomimetic innovation.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42978664PubMed
42898937Reframing clathrin-mediated viral entry: evidence standards, context dependence and host-directed vulnerabilities.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42898937PubMed
41902259Advances in Nanotechnology for the Treatment of Herpes Virus Infections.Viruses2026https://conductscience.org/library/papers/41902259PubMed
41309759Lipid nanocapsule-chitosan and iota-carrageenan hydrogel composite for sustained hydrophobic drug delivery.Sci Rep2025https://conductscience.org/library/papers/41309759PubMed
41003031
Review of Current Achievements in Dendrimers and Nanomaterials for Potential Detection and Remediation of Chemical, Biological, Radiological and Nuclear Contamination-Integration with Artificial Intelligence and Remote Sensing Technologies.
Nanomaterials (Basel)2025https://conductscience.org/library/papers/41003031PubMed
40884531Pathogenic breaches: how viruses compromise blood-tissue barriers.Tissue Barriers2026https://conductscience.org/library/papers/40884531PubMed
40038154Recent Advances in Antiviral Drug Delivery Strategies.AAPS PharmSciTech2025https://conductscience.org/library/papers/40038154PubMed
39991031Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy.ACS Meas Sci Au2025https://conductscience.org/library/papers/39991031PubMed
39771562Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.Pharmaceutics2024https://conductscience.org/library/papers/39771562PubMed
38847166Nanovesicles as Potential Carriers for Delivery of Antiviral Drugs: A Comprehensive Review.Curr Drug Deliv2025https://conductscience.org/library/papers/38847166PubMed
38620592Nanoparticles as delivery vehicles for antiviral therapeutic drugs.Eng Regen2021https://conductscience.org/library/papers/38620592PubMed
38068211"To Be or Not to Be" of a Polymer Nanogel-Unravelling the Relationship of Product Properties vs. Synthesis Conditions Governing the Radiation Crosslinking of Poly(acrylic acid) Using GPC/SEC-MALLS.Materials (Basel)2023https://conductscience.org/library/papers/38068211PubMed
37894118Enhanced Anti-Herpetic Activity of Valacyclovir Loaded in Sulfobutyl-ether-β-cyclodextrin-decorated Chitosan Nanodroplets.Microorganisms2023https://conductscience.org/library/papers/37894118PubMed
37676868Synthesis of copaiba (Copaifera officinalis) oil nanoemulsion and the potential against Zika virus: An in vitro study.PLoS One2023https://conductscience.org/library/papers/37676868PubMed
37587394Metabolomics-directed nanotechnology in viral diseases management: COVID-19 a case study.Pharmacol Rep2023https://conductscience.org/library/papers/37587394PubMed
37313114Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness.J Drug Deliv Sci Technol2023https://conductscience.org/library/papers/37313114PubMed
37229148Recent Developments in Nanotechnology-Based Biosensors for the Diagnosis of Coronavirus.Plasmonics2023https://conductscience.org/library/papers/37229148PubMed
37223276Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer.Int J Nanomedicine2023https://conductscience.org/library/papers/37223276PubMed
37164241Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases.J Control Release2023https://conductscience.org/library/papers/37164241PubMed
36992450Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies.Viruses2023https://conductscience.org/library/papers/36992450PubMed

See all 77 cited byDownload CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
ALPI248PubTator's text mininghttps://conductscience.org/library/genes/248NCBI Gene
CCR51234PubTator's text mininghttps://conductscience.org/library/genes/1234NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CMPK2129607PubTator's text mininghttps://conductscience.org/library/genes/129607NCBI Gene
DCK1633PubTator's text mininghttps://conductscience.org/library/genes/1633NCBI Gene
ELN2006PubTator's text mininghttps://conductscience.org/library/genes/2006NCBI Gene
F32152PubTator's text mininghttps://conductscience.org/library/genes/2152NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
NEU14758PubTator's text mininghttps://conductscience.org/library/genes/4758NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
RNASEL6041PubTator's text mininghttps://conductscience.org/library/genes/6041NCBI Gene
RNF13055819PubTator's text mininghttps://conductscience.org/library/genes/55819NCBI Gene
SDC26383PubTator's text mininghttps://conductscience.org/library/genes/6383NCBI Gene
TF7018PubTator's text mininghttps://conductscience.org/library/genes/7018NCBI Gene
TFRC7037PubTator's text mininghttps://conductscience.org/library/genes/7037NCBI Gene
TMED210959PubTator's text mininghttps://conductscience.org/library/genes/10959NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32085535

GET https://conductscience.org/api/papers/v1/32085535/references?page=2